Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.09, read 2026-11-04
Ethical does not pass the values gate
Price20.23 USD
Fair value22.00
Ethical score70.0/100
Value readFairas of 4 Nov 2026
Our investment reviews on this name
2026-11-01Read Markdown20.18+0.2% to today Accumulation gives way to Markdown
2026-10-02Read Accumulation20.99-3.6% to today Markup gives way to Accumulation after a 34% rise in 4 weeks
2026-09-05Read Markup15.71+28.8% to today ✓Distribution gives way to Markup after a 16% slide in 9 weeks
2026-07-02Read Distribution18.65+8.5% to today First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Mistras Group Inc holds its Markdown at $20.23. Consolidating, no directional conviction, held for 36 days.
As held on the ledger · 2026-11-04
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 36 days
Price at the screen
$20.23
Valuation
29.99 trailing · 16.86 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.89
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
36.84%
Below 33%
Interest-bearing debt is 36.8% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
31.56%
Below 49%
Money owed to the company is 31.6% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Mistras's business is in a permissible area, but its interest-bearing debt is about 37% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when MG's ethical verdict changes
Today MG does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 4 Nov 2026: it trades at roughly an 8% discount to our $22.00 fair value, none competitive moat, 4.60% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 8.0% discount to the base estimate.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
MG trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-01Markdown · changed$20.18-3.2%Entry 9
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 136%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (2 analysts) rates it none, with a mean price target of $21.
2026-10-25Accumulation$20.84+0.0%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 32% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 136%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (2 analysts) rates it none, with a mean price target of $21.
2026-10-18Accumulation$20.84-0.7%Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 136%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (2 analysts) rates it none, with a mean price target of $21.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 33.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 136%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (2 analysts) rates it none, with a mean price target of $21. Since the last review it its composite score eased.
2026-09-05Markup · changed$15.71+0.0%Entry 5
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 136%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (2 analysts) rates it none, with a mean price target of $21.
2026-08-05Distribution$15.71-15.8%Entry 4
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 15.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 136%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (2 analysts) rates it none, with a mean price target of $21.
2026-07-18Distribution$18.65+0.0%Entry 3
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 136%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (2 analysts) rates it none, with a mean price target of $21.
2026-07-03Distribution$18.65+0.0%Entry 2
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Distribution$18.65Entry 1
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.